Home/Pipeline/m‑CAR‑NK (iPSC‑derived)

m‑CAR‑NK (iPSC‑derived)

B‑cell lymphoma

PreclinicalActive

Key Facts

Indication
B‑cell lymphoma
Phase
Preclinical
Status
Active
Company

About LambdaGen Therapeutics

Platform biotech using λ‑integrase for precise, large‑payload genome insertion to create next‑gen cell‑therapy and protein‑production solutions.

View full company profile

Therapeutic Areas